Béhé M - Search Results

1

CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.

Nock BA, Maina T, Béhé M, Nikolopoulou A, Gotthardt M, Schmitt JS, Behr TM, Mäcke HR. Nock BA, et al. Among authors: behe m. J Nucl Med. 2005 Oct;46(10):1727-36. J Nucl Med. 2005. PMID: 16204724 Free article.

2

Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.

Behr TM, Béhé MP. Behr TM, et al. Among authors: behe mp. Semin Nucl Med. 2002 Apr;32(2):97-109. doi: 10.1053/snuc.2002.31028. Semin Nucl Med. 2002. PMID: 11965605 Review.

3

Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.

Béhé M, Kluge G, Becker W, Gotthardt M, Behr TM. Béhé M, et al. J Nucl Med. 2005 Jun;46(6):1012-5. J Nucl Med. 2005. PMID: 15937313 Free article.

4

Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.

Gotthardt M, Béhé MP, Beuter D, Battmann A, Bauhofer A, Schurrat T, Schipper M, Pollum H, Oyen WJ, Behr TM. Gotthardt M, et al. Among authors: behe mp. Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1273-9. doi: 10.1007/s00259-006-0157-8. Epub 2006 Jul 11. Eur J Nucl Med Mol Imaging. 2006. PMID: 16832634

5

Molecular gastrin receptor localisation in mice using high-resolution SPET-MRI image fusion.

Schurrat T, Alfke H, Béhé M, Maina T, Nock B, Mäcke H, Heverhagen JT, Klose KJ, Halling H, Behr TM, Schramm N. Schurrat T, et al. Among authors: behe m. Eur J Nucl Med Mol Imaging. 2003 May;30(5):800. doi: 10.1007/s00259-003-1141-1. Epub 2003 Mar 26. Eur J Nucl Med Mol Imaging. 2003. PMID: 12658507 No abstract available.

6

Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.

Béhé M, Behr TM. Béhé M, et al. Biopolymers. 2002;66(6):399-418. doi: 10.1002/bip.10356. Biopolymers. 2002. PMID: 12658727

7

Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.

Béhé M, Becker W, Gotthardt M, Angerstein C, Behr TM. Béhé M, et al. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1140-6. doi: 10.1007/s00259-003-1178-1. Epub 2003 May 24. Eur J Nucl Med Mol Imaging. 2003. PMID: 12768330 Clinical Trial.

8

Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.

Laverman P, Béhé M, Oyen WJ, Willems PH, Corstens FH, Behr TM, Boerman OC. Laverman P, et al. Among authors: behe m. Bioconjug Chem. 2004 May-Jun;15(3):561-8. doi: 10.1021/bc034208w. Bioconjug Chem. 2004. PMID: 15149184

9

Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?

Storch D, Béhé M, Walter MA, Chen J, Powell P, Mikolajczak R, Mäcke HR. Storch D, et al. Among authors: behe m. J Nucl Med. 2005 Sep;46(9):1561-9. J Nucl Med. 2005. PMID: 16157541 Free article.

10

[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.

Wild D, Béhé M, Wicki A, Storch D, Waser B, Gotthardt M, Keil B, Christofori G, Reubi JC, Mäcke HR. Wild D, et al. Among authors: behe m. J Nucl Med. 2006 Dec;47(12):2025-33. J Nucl Med. 2006. PMID: 17138746 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters